TELA
TELA Bio, Inc. · Healthcare
Insiders bought $4.2M of TELA Bio, Inc. in the last 12 months
2 insiders bought on 3 days.
TELA over the last year
Largest buyers, last 12 months
TELA after insider buys
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Every filing
60 insider filings since 2019, newest first
Joseph H Capper · Director
Joseph H Capper · Director
Ew Healthcare Partners Fund 2, L.P. · 10% owner
Orbimed Advisors LLC · 10% owner
Ew Healthcare Partners Fund 2, L.P. · 10% owner
Orbimed Advisors LLC · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Opaleye Management Inc. · 10% owner
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Roberto Cuca · COO and CFO
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
Ew Healthcare Partners Fund 2, L.P. · See footnote 2
About TELA Bio, Inc.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.